Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2008

01-08-2008 | Image of the Month

Whole body 18fluoro-l-dopa PET–CT: a useful tool for location and surgical guidance in primary carcinoid tumours

Authors: J. Arbizu, M. Rodriguez-Fraile, I. Dominguez-Prado, P. Garrastachu, F. Rotellar, B. Sangro, J. A. Richter

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2008

Login to get access

Excerpt

Neuroendocrine tumours (NETs) represent a diagnostic and therapeutic challenge. Primary tumour is not localised in 20% to 50% of NETs, midgut carcinoids being particularly elusive [1]. 18Fluoro-l-dopa has emerged as a new imaging tool for NETs diagnosis with improved tumour detection and staging compared with conventional imaging (SRS and/or CT) [2, 3]. We present a patient with metastatic carcinoid tumour who underwent PET–CT scan with 18fluoro-l-dopa, which was of key importance to locate the primary tumour and guide its surgical resection. …
Literature
1.
go back to reference Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61–72.PubMedCrossRef Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61–72.PubMedCrossRef
2.
go back to reference Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, et al. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 2006;7:728–34.PubMedCrossRef Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, et al. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 2006;7:728–34.PubMedCrossRef
3.
go back to reference Ambrosini V, Tomassetti P, Rubello D, Campana D, Nanni C, Castellucci P, et al. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. Nucl Med Commun 2007;28:473–7.PubMedCrossRef Ambrosini V, Tomassetti P, Rubello D, Campana D, Nanni C, Castellucci P, et al. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. Nucl Med Commun 2007;28:473–7.PubMedCrossRef
4.
go back to reference Pearse AG. The APUD cell concept and its implications in pathology. Pathol Annu 1974;9:27–41.PubMed Pearse AG. The APUD cell concept and its implications in pathology. Pathol Annu 1974;9:27–41.PubMed
Metadata
Title
Whole body 18fluoro-l-dopa PET–CT: a useful tool for location and surgical guidance in primary carcinoid tumours
Authors
J. Arbizu
M. Rodriguez-Fraile
I. Dominguez-Prado
P. Garrastachu
F. Rotellar
B. Sangro
J. A. Richter
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0801-6

Other articles of this Issue 8/2008

European Journal of Nuclear Medicine and Molecular Imaging 8/2008 Go to the issue